Ledipasvir 13C2 D6
| Product Name | Ledipasvir 13C2 D6 |
|---|---|
| Alternate Names | Ledipasvir Stable Isotopes, Stable Isotopes of Ledipasvir |
| CAT No. | CS-O-11807 |
| CAS No. | 1256388-51-8(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 897.02 g/mol |
| Mol. For. | C₄₇¹³C₂H₄₈D₆F₂N₈O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ledipasvir |
| Purity | 95% |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C(N1CC2(CC2)C[C@H]1C3=NC=C(C4=CC=C(C5=CC=C(C6=CC=C7C(NC([C@H]([C@@H]8C[C@H]9CC8)N9C(C(C(C)C)NC(OC)=O)=O)=N7)=C6)C=C%105)C(C%10(F)F)=C4)N3)C(C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])([2H])NC(OC)=O |
| Canonical Smiles | CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC |
| InchIKey | VRTWBAAJJOHBQU-KMWAZVGDSA-N |
| Inchl | InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1 |
| IUPAC | methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ledipasvir 13C2 D6 is a stable isotope-labeled form of Ledipasvir, which is a direct-acting antiviral medication used for the treatment of hepatitis C virus (HCV) infection. The isotope-labeled form of Ledipasvir is used as a reference standard for various applications in the pharmaceutical industry, including drug metabolism studies, pharmacokinetic analysis, and clinical trials.
The chemical formula of Ledipasvir 13C2 D6 is C49H50D6F4N8O8S2, and its molecular weight is 1008.17 g/mol. It is a white to off-white crystalline powder that is soluble in water, methanol, ethanol, and acetonitrile.
The mechanism of action of Ledipasvir involves inhibition of the HCV non-structural protein NS5A, which is essential for viral replication. The drug works by binding to the NS5A protein and preventing its interaction with other viral proteins, thereby inhibiting the assembly and release of new virus particles.
The use of Ledipasvir 13C2 D6 as a reference standard helps researchers to accurately measure the concentration of Ledipasvir and its metabolites in biological samples. This information is essential for determining the pharmacokinetic properties of the drug and optimizing its dosing regimen. Overall, the availability of stable isotope-labeled drugs like Ledipasvir 13C2 D6 has significantly improved drug development and clinical research in the field of pharmaceuticals.
Get an Instant Quote
Related Compounds
Ledipasvir D6 | Ledipasvir D8 | Ledipasvir D16 |